Medicines Discovery Catapult
Medicines Discovery Catapult's email is info@md.catapult.org.uk
.
View Top Employees for Medicines Discovery Catapult
Industry | Biotechnology | |
Location | Cheshire, United Kingdom | |
Employees | 30 | |
Founded | 2016 |
HQ | Block 35, Mereside Alderley Park | |
info@md.catapult.org.uk | ||
Funding | 0 | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Industry | Biotechnology | |
Location | Cheshire, United Kingdom | |
Employees | 30 | |
Founded | 2016 | |
linkedin.com/company/medicines-discovery-catapult | ||
HQ | Block 35, Mereside Alderley Park | |
info@md.catapult.org.uk | ||
Funding | 0 |
Top Competitors for Medicines Discovery Catapult
Medicines Discovery Catapult Questions
Where are Medicines Discovery Catapult's headquarters?
Medicines Discovery Catapult's headquarters are in Block 35, Mereside Alderley Park
How many employees are working in Medicines Discovery Catapult right now?
Medicines Discovery Catapult has
30 employees.
View the Email and Phone Numbers for all 30 working at Medicines Discovery Catapult.
What is Medicines Discovery Catapult's industry?
Medicines Discovery Catapult's industry is
Biotechnology
Who are Medicines Discovery Catapult's top competitors?
Medicines Discovery Catapult's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Medicines Discovery Catapult's email address?
Medicines Discovery Catapult's email address is info@md.catapult.org.uk
What are Medicines Discovery Catapult's categories?
Medicines Discovery Catapult's categories are Association, Pharmaceutical
What is Medicines Discovery Catapult's location?
Medicines Discovery Catapult's location is
Cheshire, United Kingdom
When was Medicines Discovery Catapult's founded?
Medicines Discovery Catapult's founding year is 2016
What is Medicines Discovery Catapult's funding?
Medicines Discovery Catapult's funding is 0
What is Medicines Discovery Catapult's current status?
Medicines Discovery Catapult's current status is operating